Search research articles
Contact Us
Filters
Showing results (791-800 of 831) with videos related to
Page
of 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2019
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial
Hyman B Muss, Mei-Yin C Polley, Donald A Berry, et al.
The Lancet. Oncology
|
March 1, 2023
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
Sara M Tolaney, Paolo Tarantino, Noah Graham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
P Tarantino, G Viale, M F Press, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2019
DNA Methylation Markers for Breast Cancer Detection in the Developing World
Bradley M Downs, Claudia Mercado-Rodriguez, Ashley Cimino-Mathews, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 2024
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R A Freedman, H M Heiling, T Li, et al.
Archives of Pathology & Laboratory Medicine
|
June 8, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Journal of the National Cancer Institute
|
May 1, 2019
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Aleix Prat, Tomás Pascual, Carmine De Angelis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 10, 2012
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines
Robert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Journal of Medicinal Chemistry
|
February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead
N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Archives of Pathology & Laboratory Medicine
|
July 1, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Page
of 84
Search research articles
Search
Showing results (791-800 of 831) with videos related to
Sort By:
Page
of 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2019
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial
Hyman B Muss, Mei-Yin C Polley, Donald A Berry, et al.
The Lancet. Oncology
|
March 1, 2023
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
Sara M Tolaney, Paolo Tarantino, Noah Graham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
P Tarantino, G Viale, M F Press, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2019
DNA Methylation Markers for Breast Cancer Detection in the Developing World
Bradley M Downs, Claudia Mercado-Rodriguez, Ashley Cimino-Mathews, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 2024
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R A Freedman, H M Heiling, T Li, et al.
Archives of Pathology & Laboratory Medicine
|
June 8, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Journal of the National Cancer Institute
|
May 1, 2019
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Aleix Prat, Tomás Pascual, Carmine De Angelis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 10, 2012
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines
Robert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Journal of Medicinal Chemistry
|
February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead
N G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.
Archives of Pathology & Laboratory Medicine
|
July 1, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Page
of 84